NCT03769467 · Interventional trial
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Epstein-Barr Viraemia, Epstein-Barr Virus Infections, Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC), Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms
Delaware Valley sites
- University of Pennsylvania (Adults and Pediatrics) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory